1. Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study 
Song Wan, MD, PhD, Jean-Louis LeClerc, MD, Martine Antoine, MD, Jean-Marie DeSmet, MD, Anthony P.C Yim, MD, Jean-Louis Vincent, MD, PhD 
The Annals of Thoracic Surgery 
Volume 68, Issue 4, Pages (October 1999)
DOI: /S (99)

2. Fig 1
Plasma levels of endotoxin in patients undergoing heart and heart-lung transplantation with heparin-coated (HC) or noncoated (NHC) extracorporeal circuits. Data are mean ± SEM. (BH = before heparin administration; CC = immediately after aortic cross-clamping; DC = 5 minutes after aortic declamping; 0.5h, 1h, 1.5h, 2h, 12h, 24h = time points after declamping.)
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

3. Fig 2
Plasma levels of interleukin (IL)-6 (A), IL-8 (B), IL-10 (C) and IL-12 (D) in patients undergoing heart and heart-lung transplantation with heparin-coated (HC) or noncoated (NHC) extracorporeal circuits. (Sampling time points: see legend of Fig 1.)
The Annals of Thoracic Surgery  , DOI: ( /S (99) )

4. Fig 3
Plasma levels of cardiac troponin-I (cTnI) in patients undergoing heart and heart-lung transplantation with heparin-coated (HC) or noncoated (NHC) extracorporeal circuits. (Sampling time points: see legend of Fig 1.)
The Annals of Thoracic Surgery  , DOI: ( /S (99) )